Atlas Trials

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Clinical trial NCT04174599 · COMPLETED

Trial details

NCT number
NCT04174599
Sponsor
EVIVE Biotechnology
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerNeutropenia
Start date
2018-04-12
Primary completion
2019-01-24
Enrollment
242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.